133.27
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Sinocare Challenges Abbott's Glucose Monitor Patents - Law360
Mizuho Adjusts Price Target on Abbott Laboratories to $140 From $135, Maintains Neutral Rating - MarketScreener
Why analysts recommend Abbott Laboratories (ABL) stock2025 Risk Factors & Free Fast Entry Momentum Trade Alerts - newser.com
Abbott Laboratories To Go Ex-Dividend On October 15th, 2025 With 0.59 USD Dividend Per Share - 富途牛牛
Abbott Laboratories (ABT) Q3 Earnings Report Preview: What To Look For - FinancialContent
Ex-Dividend Reminder: Abbott Laboratories, AbbVie and ARMOUR Residential REIT - Nasdaq
Vest Financial LLC Boosts Stock Holdings in Abbott Laboratories $ABT - MarketBeat
MOKAN Wealth Management Inc. Has $2.99 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Welch Group LLC Grows Position in Abbott Laboratories $ABT - MarketBeat
Pathway Financial Advisors LLC Sells 3,588 Shares of Abbott Laboratories $ABT - MarketBeat
Precision Trading with Abbott Laboratories (ABT) Risk Zones - news.stocktradersdaily.com
Volatility clustering patterns for Abbott LaboratoriesWeekly Trend Report & Fast Gain Stock Tips - newser.com
Mitchell Sinkler & Starr PA Sells 70,137 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Sold by Natural Investments LLC - MarketBeat
Abbott Laboratories $ABT Stock Holdings Increased by Fifth Third Wealth Advisors LLC - MarketBeat
Cwm LLC Raises Position in Abbott Laboratories $ABT - MarketBeat
DSM Capital Partners LLC Sells 81,763 Shares of Abbott Laboratories $ABT - MarketBeat
Johnson Investment Counsel Inc. Lowers Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Raised by Concurrent Investment Advisors LLC - MarketBeat
Sivik Global Healthcare LLC Decreases Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Those who invested in Abbott Laboratories (NYSE:ABT) three years ago are up 39% - Yahoo Finance
Benchmark Initiates Coverage on Abbott Laboratories (NYSE:ABT) - MarketBeat
PDS Planning Inc Increases Stake in Abbott Laboratories $ABT - MarketBeat
Wealthstar Advisors LLC Decreases Position in Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories (ABT) Affects Rotational Strategy Timing - news.stocktradersdaily.com
McKinley Carter Wealth Services Inc. Purchases 15,362 Shares of Abbott Laboratories $ABT - MarketBeat
Ramirez Asset Management Inc. Increases Position in Abbott Laboratories $ABT - MarketBeat
Aberdeen Group plc Purchases 81,094 Shares of Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Stake Trimmed by Coerente Capital Management - MarketBeat
Abbott Laboratories $ABT Shares Acquired by Eastern Bank - MarketBeat
Horizon Bancorp Inc. IN Has $781,000 Stake in Abbott Laboratories $ABT - MarketBeat
Benchmark Initiates Coverage of Abbott Laboratories (ABT) with Buy Recommendation - Nasdaq
Abbott Laboratories (ABT): Exploring Valuation After Recent Shareholder Returns and Growth Prospects - simplywall.st
Abbott gets FDA breakthrough nod for dual-energy ablation catheter - MassDevice
Abbott is a steady Medtech company in an unsteady world, says Benchmark - Investing.com
Therapeutic Drug Monitoring (TDM) Market Size Expected to Reach USD 2.80 Bn by 2034 - GlobeNewswire Inc.
Abbott to Report Q3 Earnings: Medical Devices Arm in Focus - The Globe and Mail
US Bancorp DE Has $390.37 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Wall Street's Insights Into Key Metrics Ahead of Abbott (ABT) Q3 Earnings - Nasdaq
Abbott (ABT) Receives Buy Rating with Bullish Outlook - GuruFocus
Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Abbott Laboratories: Diversified Growth and Strategic Investments Justify Buy Rating - TipRanks
Abbott Laboratories $ABT Shares Bought by Callan Family Office LLC - MarketBeat
Can Abbott Laboratories Deliver On Q3 Earnings Expectations? - RTTNews
Is Abbott Laboratories (ABL) stock cheap by valuation metrics2025 Earnings Surprises & Daily Entry Point Trade Alerts - newser.com
Pedialyte class action claims ‘healthy’ hydration drinks contain harmful artificial sweetener - Class Action Lawsuits
Abbott adds Laralab AI-based cardiac imaging tech - MassDevice
Abbott Laboratories: There May Be A Surge Coming Next Week (Earnings Preview) (ABT) - Seeking Alpha
First Merchants Corp Sells 4,988 Shares of Abbott Laboratories $ABT - MarketBeat
Maryland State Retirement & Pension System Has $11.45 Million Position in Abbott Laboratories $ABT - MarketBeat
Fluent Financial LLC Has $4.34 Million Stock Holdings in Abbott Laboratories $ABT - MarketBeat
Kingswood Wealth Advisors LLC Has $1.12 Million Holdings in Abbott Laboratories $ABT - MarketBeat
How Abbott Laboratories stock compares to growth peersJuly 2025 Snapshot & Stock Portfolio Risk Control - newser.com
Abbott Labs Is UBS’s Top MedTech Value Play For Growth - Finimize
Abbott Laboratories (NYSE:ABT) Given "Buy (B)" Rating at Weiss Ratings - MarketBeat
UBS reiterates Buy rating on Abbott Labs stock, citing undervalued growth - Investing.com
Puzo Michael J Trims Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT is Broderick Brian C's 7th Largest Position - MarketBeat
WoodTrust Financial Corp Acquires 8,165 Shares of Abbott Laboratories $ABT - MarketBeat
Triasima Portfolio Management inc. Buys New Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT is Hendley & Co. Inc.'s 5th Largest Position - MarketBeat
Abbott Laboratories $ABT Shares Sold by NBT Bank N A NY - MarketBeat
Somerville Kurt F Has $21.58 Million Holdings in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Bought by BankPlus Trust Department - MarketBeat
SteelPeak Wealth LLC Increases Position in Abbott Laboratories $ABT - MarketBeat
Knights of Columbus Asset Advisors LLC Takes $329,000 Position in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories (ABT): A Healthcare Leader Powering the List of Profitable Dividend Stocks - MSN
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):